A dynamic environment for clinical research is one of the most important cornerstones in ensuring future growth for the Life Science community in Medicon Valley. Clinical development provide new research, knowledge and skills and give patients access to new and often life-saving, medical treatment.
However, the clinical research activity has faced dramatic falls in both Sweden and Denmark over a number of years. Fierce competition from foreign markets and a pressured agenda for public health care institutions, have been mentioned as explanations for the negative trend.
Medicon Valley has excellent platforms for performing qualitative clinical research, but how can we regain our leading position?
At the Annual Meeting of Medicon Valley Alliance we have asked Novo Nordisk and AstraZeneca to set the scene for and benchmark Medicon Valley towards the rest of the world in terms of clinical trials. Together with researchers, hospitals and policymakers the two companies will discuss what it takes to regain Medicon Valley’s position on the “world map of clinical research”.
Date & Time: Thursday 29 November 2012, 13:00-19:00
Venue: Hilton Copenhagen Airport, Ellehammersvej 20, Kastrup, Denmark
Moderator: Jens Gaardbo
Register: To register please go to the bottom of this page.
13.00 Registration and welcome drink
Stig Jørgensen, CEO, Medicon Valley Alliance
13.40 The Global Hotspots for Clinical Research
Astra Zeneca has cut down significantly on their activity in Sweden and Novo Nordisk's growth in R & D is primarily in emerging markets outside Denmark. How do the two companies assess the attractiveness of Medicon Valley in terms of clinical research and which global hotspots for clinical research are the most interesting?
Anders Dejgaard, Corporate Vice President, CMO, Novo Nordisk
Håkan Larsson, Sweden Science Relations Lead, AstraZeneca
14.45 How to Attract Big Pharma
Is Medicon Valley attractive to Pfizer in terms of clinical research? And how can politicians improve framework conditions on clinical research in Medicon Valley in order to attract international Big Pharma?
Tolga Tanguler, Head, Specialty Care, Pfizer Denmark
15.00 The Political Agenda
How do the politicians plan to support clinical research in Denmark and Sweden?
Astrid Krag, Health Minister in Denmark
Peter Honeth, State Secretary for Research, Swedish Ministry of Education and Research
15.35 Break - Networking
16.15 Collaborative Applied Clinical Research - results from a Nordic Study
Olav Flaten MD PhD, NRI networks, Medical Director, GlaxoSmithKline, London
16.35 Attracting Clinical Research to Region Skåne
Rita Jedlert, Deputy Medical Director, Region Skåne
16.55 Key Problems and Solutions from a Danish Perspective
Poul Jaszczak, Chairman of The Danish National Forum for Health Research; Consultant, Dr. med Sci.
17.10 Panel Discussion
Sophie Hæstorp Andersen, Member of the Danish Parliament, The Social Democratic Party
Bengt Wittgren, Deputy Director General, Swedish Medical Products Agency
Ida Sofie Jensen, CEO, The Danish Association of the Pharmaceutical Industry (LIF)
Carsten Rose, Head of Division, Professor Oncology, Skåne University Hospital, Sweden
Michael Lange, Head of Public Affairs, Novartis Denmark, and member of The Region Council for The Liberal Party of Denmark, The Capital Region of Denmark
18.00 Networking, drinks and canapés
The event is part of the project ”Medicon Valley – a world-class life science region”. It is a three year project by Medicon Valley Alliance in collaboration with Invest in Skåne. The project is partly financed by EU Interreg IV Programme.
One-to-one meeting with the Life Science Ambassadors
Medicon Valley Alliance's Life Science Ambassadors are attending the Annual Meeting. If you would like to book an one-to-one meeting in connection with the Annual Meeting please contact Ann-Sofie Andersson.
Interested in staying the night over?
Hilton has a special offer for you in connection with the Annual Meeting. Book your hotel room here.
Register to the Annual Meeting
Please register by filling in the form below, latest Thursday 22 November.
We use the input data as it is written for name tags and list of participants, and the email for further information prior to the Annual Meeting.